being and becoming in the world
Confirmed symposia for next year’s Summer Meeting of the British Association for Psychopharmacology [BAP] indicate an increasing defensiveness: BAP ‘symposia’ are generally sponsored by the pharmaceutical industry. BAP meetings continue … Continue reading ‘Preliminary’
Industry funding and self-censorship. This letter by Peter Doshi, Kim Witczak and Linda Wastila was published in the BMJ on 19 September 2023.
This article by Helen McArdle featured in the Herald on the 9th September 2023. Professor David Nutt, a career-long paid opinion leader for the pharmaceutical industry, is quoted and presents … Continue reading “Psychedelic drugs could soon treat alcoholism”
